Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 81 - 100 results of 8,724 for search '(( significantly ((we decrease) OR (nn decrease)) ) OR ( significant clinical decrease ))', query time: 0.58s Refine Results
  1. 81
    The Human Disharmony Loop Clinical Presentation.

    The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Projected global leukemia burden, 1990-2050.

    Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 83
    Correlation between HDI and EAPC.

    Correlation between HDI and EAPC. by Chengjun Hu (588206)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Global leukemia incidence and EAPC, 1990-2021.

    Global leukemia incidence and EAPC, 1990-2021. by Chengjun Hu (588206)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Clinical and epidemiological characteristics.

    Clinical and epidemiological characteristics. by Domingos L. S. Rios (20496173)

    Published 2025
    “…However, large studies providing a comprehensive longitudinal observation of patients undergoing this therapy are lacking. We evaluated the effectiveness of treating severe obesity in hospitalized patients, using very low-calorie diets and clinical support to develop lifestyle changes. …”
    Save to List
    Saved in:
  6. 86
    Grade system.

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Literature search.

    Literature search. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Study characteristics.

    Study characteristics. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Flowchart of literature retrieval.

    Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Data extraction.

    Data extraction. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Cochrane Collaboration’s risk of bias tool.

    Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Save to List
    Saved in:
  13. 93
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Pre-RT and post RT D-dimer levels in associated with prognostic significance.

    Pre-RT and post RT D-dimer levels in associated with prognostic significance. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    B2 decreases glycolytic intermediates in cells.

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    Save to List
    Saved in:
  16. 96
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  17. 97
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Save to List
    Saved in:
  19. 99
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Save to List
    Saved in:
  20. 100
    Clinical and Demographic Characteristics of the Study Population.

    Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Save to List
    Saved in:

Search Tools: